Skip to content

Skin Conditioning

HUMAN CORD BLOOD PROGENITOR CELL EXOSOMES

Updated
35

Safety score · 0–100

Caution

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

Exosomes harvested from human cord blood progenitor cells, marketed for regeneration. Strong regulatory and biosafety concerns; many jurisdictions disallow human-tissue-derived cosmetics.

Function

SKIN PROTECTINGSKIN CONDITIONING - MISCELLANEOUS

Skin benefits

  • Marketed for skin regeneration
  • Contains growth-factor-like vesicles
  • Used at very low percentages

Known concerns

  • Human-derived ingredient with regulatory ambiguity
  • Risk of biological contamination if not pharma-grade
  • No CIR/SCCS review for cosmetic exosomes
  • Many regulators consider human-tissue-derived cosmetics non-compliant

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related skin conditionings

35
ACETAMIDE MEA
Skin Conditioning
 35
ACORUS CALAMUS CALLUS CULTURE EXTRACT
Skin Conditioning
 35
ACORUS CALAMUS ROOT
Skin Conditioning
 35
ARISAEMA CONSANGUINEUM ROOT EXTRACT
Skin Conditioning
 35
BEE VENOM
Skin Conditioning
 35
BENZYLADENINE
Skin Conditioning
 35
BUXUS SEMPERVIRENS LEAF EXTRACT
Skin Conditioning
 35
CAPRYL ESCHERICHIA COLI/CORN KERNEL EXTRACT/GLUCOSE FERMENT FILTRATE
Skin Conditioning

Check your shelf

Find HUMAN CORD BLOOD PROGENITOR CELL EXOSOMES in your products.

Scan any cosmetic product with LuxSense to see if it contains HUMAN CORD BLOOD PROGENITOR CELL EXOSOMES and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.